Bay Pines, FL (PRWEB) October 15, 2014
The Bay Pines VA Healthcare System will host its annual Veterans Day Ceremony on Tuesday, November 11, at 11:00 a.m. The ceremony will take place in the courtyard located buildings 2 and 37 on the C.W. Bill Young VA Medical Center Campus. The event is open to all Veterans, their family and friends, and the general public.
Highlights of the ceremony will include guest speakers from VA and U.S. Central Command; musical performances by the Keswick Christian School Choir; a special parade of colors provided by local Veteran Service Organizations; and traditional military presentations to include the posting and retiring of the U.S. Flag, a firing salute, a taps performance and more.
Local news anchor Reginald Roundtree will be the master of ceremonies for the event.
For the Bay Pines VA Healthcare System, every day is Veterans Day; however, our annual ceremony provides a unique and wonderful opportunity for the community to join us to honor Veterans and active duty service members, said Suzanne M. Klinker, Director, Bay Pines VA Healthcare System.
Last year, nearly 2,000 people joined us during our annual Veterans Day ceremony to honor the men and women who served and continue to serve our great nation, she said. We anticipate another great event this year as we come together once again to pay tribute to Americas heroes.
Important note for attendees and local media:
Signage will be posted on the medical center campus to direct visitors to the venue. Reserved and general parking will be available nearby. A shuttle service will also be available to provide transportation for guests from parking lots to the ceremony area. The event will take place outdoors. The Bay Pines VAHCS encourages all attendees to dress appropriately in the event of inclement weather. For driving directions, a campus maps and more please visit http://www.baypines.va.gov/locations/directions.asp.
Media members are encouraged to contact the Bay Pines VAHCS Office of Public Affairs at vhabaypublicaffairs(at)va(dot)gov or 727-398-9531 for advanced information about the ceremony.
About the Bay Pines VA Healthcare System
The Bay Pines VAHCS is one of the nations leading VA healthcare systems, employing more than 3,800 medical professionals and support staff dedicated to providing the very best care to Veterans residing in southwest Florida. The organization is the fourth busiest VA health care system in the country in terms of patients served and is accredited by The Joint Commission, Commission on Accreditation of Rehabilitation Facilities, and several other nationally recognized accrediting organizations. The Bay Pines VAHCS operates nine facilities to include the main medical center located in Bay Pines and outpatient clinics located in Bradenton, Cape Coral, Naples, Palm Harbor, Port Charlotte, Sarasota, St. Petersburg, and Sebring. To learn more, please visit http://www.baypines.va.gov or like us on Facebook at http://www.facebook.com/vabaypines.
Cообщество ВИА ГРА – ttps://www.youtube.com/user/ELLO/video?x=viagra Подпишись на новые клипы – http://bit.ly/Podpiska @ Google+ http://google.com/+ELLO…
Video Rating: 4 / 5
New York, NY (PRWEB) September 14, 2014
Transvaginal mesh (http://www.injurybeacon.com/transvaginal-mesh/) lawsuits are continuing to be filed in New Jersey, where two separate litigations are moving forward in Atlantic County Superior Court, Bernstein Liebhard LLP reports.
According to Case Lists updated on September 5th, thousands of lawsuits have now been filed over devices marketed by C.R. Bard Inc., and Johnson & Johnsons Ethicon unit. In a consolidated proceeding involving cases against C.R. Bard, a total of 1,557 claims have now been filed, while the litigation involving Ethicons Gynecare product line now includes more than 7,000 lawsuits. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10) (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
We are not surprised that the number of lawsuits continues to increase in the two mesh litigations underway in Atlantic County, as our Firm regularly hears from women who received implants from Ethicon, C.R. Bard and other companies, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who may have suffered pain, erosion, scarring, infection and other side effects allegedly caused by transvaginal mesh.
Transvaginal Mesh Lawsuits
Transvaginal mesh lawsuits have continued to increase since 2008, when the U.S. Food and Drug Administration (FDA) first warned about their potential to cause serious injuries. At the time, the FDA said it received at least 1,000 reports of serious injuries associated with pelvic mesh implants over three years. In July 2011, the federal agency issued a second Public Health Alert indicating that the number of transvaginal mesh injury reports had tripled since 2008. The FDA said at the time that such injuries were not rare, which was a modification of its previous stance that they were rare.
The nationwide law firm of Bernstein Liebhard LLP is actively involved in New Jerseys consolidated mesh litigations. Firm partner, Jeffrey S. Grand, is currently serving as Co-Liaison Counsel in both the C.R. Bard and Ethicon proceedings. For the Ethicon litigation, Mr. Grandwas also a member of the Plaintiffs trial team in a case that concluded in March 2013 with an $ 11 million damage award to a woman who was injured by the companys Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)
At the federal court level, transvaginal mesh lawsuits are moving forward as well. Court documents show 19,380 Ethicon lawsuits now filed in a multidistrict litigation established in the U.S. District Court, Southern District of West Virginia, where nearly 9,600 claims over C.R. Bard have now been centralized in a separate proceeding established there. Mr. Grand is serving on the Plaintiffs Steering Committee in both these litigations, as well as those involving American Medical Systems, Inc. and Boston Scientific Corp. (Ethicon, Inc. (MDL No. 2327), American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
On September 5th, the jury hearing the second bellwether trial in the federal Ethicon litigation returned a $ 3.27 million verdict in favor of a woman who suffered complications related to erosion of her Gynacare TVT O-Mesh device. (Huskey v. Ethicon, Case No. 12-5201)
Just days later, a jury in Texas state court ordered on September 8th that Boston Scientific pay $ 73 million in compensatory and punitive damage to a woman who was harmed by the companys Obtryx sling. (Salazar v. Lopez, No. DC-1214349, District Court for Dallas County, 95th Judicial District of Texas (Dallas))
According to court documents, all transvaginal mesh lawsuits filed in these litigations allege chronic pain, scarring, painful sexual intercourse and other injuries caused by the implants. Plaintiffs further accuse manufacturers of failing to adequately warn doctors and patients about risks that may be associated with their products.
Women who were allegedly injured as a result of transvaginal mesh may be able to pursue their own legal claim against the manufacturer of their device. Learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP’s website or the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by
The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
Toronto, ON (PRWEB) October 11, 2014
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on research that suggests a new way to tackle food addiction.
As Bel Marra Health reports in its article (http://www.belmarrahealth.com/brain-function/harvards-scientific-trick-healthy-food-becomes-irresistible/), a new study has found a way to train the brain to like healthy foods that some find less than palatable.
The study, conducted by Harvard Medical School and Tufts University and published in the journal Nutrition & Diabetes, has revealed that unhealthy foods like donuts and chips can be made less appealing to the brain while healthier food can be made more appealing.
The brain is plastic when it comes to food addiction. Circuits in the brains reward center can be completely reversed. That can mean good things for your health, if the new information is used properly.
We dont start out in life loving French fries and hating, for example, whole wheat pasta, says senior author Susan Roberts, who teaches at Tufts Friedman School of Nutrition Science and Policy.
This conditioning happens over time in response to eating repeatedly what is out there in the toxic food environment.
Researchers looked at the brains of 13 overweight and obese men and women. Eight of the participants were enrolled in a six-month behavioral weight-loss program designed by Tufts University while the remaining participants were not. All participants underwent brain scans at the beginning and end of the program.
The researchers found those who followed the weight-loss program lost a significant amount of weight, 6 kg on average, while the others put on an average of 2 kg.
The first group also saw an increase in the activity of their brains reward center that was only activated as a response to seeing images of low-calorie healthy foods at the end of the program and decreased activity in response to high-calorie foods.
Spokesperson for Bel Marra Health Dr. Victor Marchione says, Food addiction is a very real concern. Make sure you notice the signs and take steps to make changes. Bad food habits can be hard to break the longer you hold onto them.
A common sign you may be experiencing a food addiction is if you are using food to feel better, or as a reward for overcoming an emotional issue. Food addicts will need to break the cycle of eating for reward to overcome the addiction.
This study brings new hope to overweight individuals looking to break the cycle and establish good eating habits.
(SOURCE: Deckersbach T., et al., Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention, Sept. 2014; doi: 10.1038/nutd.2014.26.)
Bel Marra Health is the maker of Liver Rescue, a high-quality nutritional supplement to help support and maintain liver health. All ingredients are backed with scientific evidence. Every product is tested for safety, quality and purity at every stage of the manufacturing process.
Bel Marra Health products are produced only in Health Canada approved facilities to ensure our customers are getting top-quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.
(PRWEB) September 14, 2014
After leading the effort in achieving a strengthened fair housing law in Nassau County, which included source of income as a protected class, which took effect in 2007, ERASE Racism, as an organizer of the Housing for All Coalition, is celebrating yet another victory in the pursuit for racial equity and protection of human rights.
On Tuesday, September 10th, 2014, HR 1620 passed the Suffolk County Legislature by a unanimous vote. Advanced by County Executive Steve Bellone, the bill expands the Countys Human Rights Law to provide residents protection from discrimination in areas including housing, employment, credit, and public accommodations. According to ERASE Racism, the changes passed in the bill are a step forward for human rights in Suffolk County, benefiting a myriad of residents, including veterans, immigrants, racial and ethnic minorities, single mothers with children, and seniors.
With this passage, Suffolk now joins Nassau in expanding protections for residents against discriminatory practices. The amendments strengthen housing provisions, prohibiting discrimination against individuals based on their lawful source of income, including income derived from Social Security or housing assistance such as the Housing Choice Voucher Program (also known as Section 8). In addition these amendments prohibit realtors or sellers from refusing to make properties available to individuals based on actual or perceived race, national origin, citizenship status, gender, sexual orientation, military status, and disability, among other things. The adoption of this bill not only protects Suffolk County residents against all forms of discrimination but promotes residential racial integration and economic equality.
ERASE Racism is especially pleased that residents of Suffolk County no longer have to face housing discrimination because of their source of income. In strengthening the Human Rights Law and furthering fair housing choice, ERASE Racism commends County Executive Steve Bellone and the Suffolk County Legislature for this action,” remarked ERASE Racism President Elaine Gross.
Please visit ERASE Racism’s website to view Elaine Grosss testimony in support of the bill.
About ERASE Racism: ERASE Racism is a regional organization that leads public policy advocacy campaigns and related programmatic initiatives to promote racial equity in areas such as housing, public school education and healthcare. It engages in a variety of research, education and consulting activities to identify and address institutional and structural racism, primarily on Long Island.
Miami, FL & Astoria, NY (PRWEB) July 16, 2014
Dr. Victor Loria D.O., a Miami, Florida & Astoria, New York-based cosmetic surgeon, has pioneered a minimally invasive medical procedure that successfully increases the girth of the flaccid and erect penis, lengthens the flaccid penis, enlarges the scrotum, and now also enlarges the glans or head of the penis. The phallus enlargement treatment is a medical procedure involving the insertion of permanent fillers, resulting in an increase in penis girth of up to 3 inches, flaccid length of up to 6 inches or more and now glans enlargement up to 20-30% in the first treatment.
“I am continuously researching new minimally invasive techniques to accomplish great results in the male enhancement field,” said Dr. Loria, a pioneer in the field of penis enlargement surgery.
New penile flaccid and erect lengthening treatments are currently under investigation and experimental trials will begin by the end of this year, says Dr. Loria.
The doctor has performed thousands of cosmetic procedures over the past 20 years. He has been successfully treating men with FDA approved medications for over three years. These products are permanent and are similar to those used in facial-filler treatments.
There are invasive surgeries, as well as liposuction fat transfer and dermal grafting, all of which carry significant risks of complications.
“I don’t perform risky surgery or use temporary fillers. The fillers I use in my ‘Platinum Procedure’ produce collagen and adapt to a man’s anatomy, Dr. Loria said. Bob Druy, one of Dr. Lorias patients, is a believer. “The difference here is Dr. Lorias procedure actually works. And I’m living proof.
“There are many medical and psychological reasons why men ask how to increase penis length or to enlarge and change the shape of the penis,” said Dr. Loria.
About Dr. Loria: Dr. Victor Loria, D.O., is the medical director of the Miami-New York based Male Enhancement & Penis Enlargement Medicine & Surgery Center(call 1-877DR- LORIA or 877-375-6742).
Media Requests or Interviews: Contact Dr. Loria 786-409-5911
SOURCE Dr. Victor Loria
Columbus, OH (PRWEB) October 07, 2014
As concerns surrounding the cardiovascular side effects of AndroGel and other currently approved low testosterone treatments continue to grow, Wright & Schulte LLC notes that one pharmaceutical company is positioning its experimental medication as a superior alternative to these drugs. According to a report from Reuters, Repros Therapeutics Inc. recently announced that Androxal outperformed AndroGel in one of two clinical trials being conducted by the company. The medication, which is being developed to treat men of reproductive age with low testosterone, was associated with superior sperm concentration compared to both AndroGel and placebo. Repros said it could submit an application for Androxal approval to the U.S. Food & Drug Administration (FDA) before the end of the year.
idUSKBN0GS04B20140828, August 27, 2014]
According to Wright & Schulte LLC, the findings regarding Androxal come amid mounting safety concerns surrounding currently-approved testosterone treatments. On January 31, 2014, the FDA reported that it was investigating the cardiovascular risks that may be associated with this class of medications after two studies indicated that prescription testosterone therapy might increase the risk of heart attacks, strokes and death in older men or men with pre-existing heart problems.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]
In June, the FDA ordered the manufacturers of low testosterone treatments to add a general warning regarding a risk of blood clots to the labels of all currently approved testosterone medications. The FDA said it had received a number of reports of testosterone patients who had developed blood clots in the veins, also known as venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).
[fda.gov/drugs/drugsafety/ucm401746.htm, FDA, June 19, 2014]
On September 17, 2014, the FDA is scheduled to convene a panel of outside advisors to further explore the cardiovascular risks associated with AndroGel and other approved low testosterone therapy medications.
[foxnews.com/health/2014/07/18/fda-committee-to-discuss-adverse-effects-testosterone-products/, Reuters, July 18, 2014]
Since the FDA issued its testosterone treatment warning in January, court documents indicate that dozens of men have filed testosterone treatment lawsuits over heart problems that they allege were caused by AndroGel and similar drugs. The majority of these cases are pending in a multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, where all federally-filed testosterone lawsuits have been consolidated for coordinated pretrial proceedings. (In Re: Testosterone Products Liability Litigation, No. 42, JPML)
Men who used AndroGel or a similar testosterone treatment may be eligible to file their own low testosterone therapy lawsuit if they experienced serious and life-threatening cardiovascular events allegedly linked to the medication. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.
About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that Americas legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the worlds most powerful corporations take responsibility for their actions. If youre looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Lipitor lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
Women Hate Watching Sports, Says Men's Health Magazine
Not only is Men's Health is willing to speak truth to power by pointing out, against all evidence, that women don't actually enjoy watching sports, but they're willing to help all of us cool, good dudes with penises out by teaching us the secret that …
Read more on Deadspin
Men Receive Free Screenings at 7th Annual Men's Health Symposium
Their 7th Annual Men's Health Symposium and Screening got under way at the church on Saturday. Men received free screenings for issues like hypertension, HIV, glaucoma, diabetes and prostate irregularities. All are major issues in the African American …
Read more on TWC News
Men's Health Posts 101 Word Article, Enrages Entire Internet, Apologizes …
The worst part about this 101-word Men's Health article is that it was written by a woman. The second-worst part is the headline. The third worst part is the premise. And then there's the stock photo. Boston.com reached out to the author, Teresa Sabga …
Read more on Boston.com
Brooklyn, New York (PRWEB) September 11, 2014
Brooklyn-based startup Mesh (http://www.meshbetter.com), the first online dating service with advanced message filtering and enforced Dealbreakers, today announces the immediate availability of Mesh beta. After a successful invite-only pre-beta that has attracted major press coverage and over 1,500 active users in just eight weeks, Mesh beta is now open to everyone.
Our mission is to fix online dating and provide the best user experience possible, said Asher Snyder, founder and Chief Executive Officer of Mesh Labs Inc. Instead of being bombarded by unwanted messages, Mesh helps you focus on just the right people.
To that end, Mesh has introduced numerous game-changing features, including patent-pending Mismatch
Boston, MA (PRWEB) June 10, 2014
For the estimated half of men between the ages of 40 and 70 who have trouble getting or sustaining an erection, taking a medication can often remedy the problem. With four erectile dysfunction drugs on the market, men have options. But their choices are often limited by cost and health insurance rules, reports the June 2014 Harvard Men’s Health Watch.
Four erectile dysfunction drugs are available in the United States: avanafil (Stendra), sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra). They are meant to be taken a few hours before sexual activity. A low-dose version of tadalafil can be taken every day.
Does it make any difference which of the four erectile dysfunction drugs a man chooses? “Yes, there can be differences,” says Dr. Louis Liou, chief of urology at Harvard-affiliated Cambridge Health Alliance in Boston. “For new patients, I have them try different ones to see what works best.”
These drugs work for about 70% of men with erectile dysfunction. They generally kick in within 15 to 60 minutes (avanafil is the fastest). How long they last ranges from four hours to more than a day (tadalafil lasts longest). Side effects vary, but the most common ones are headache, flushing, upset stomach, nasal congestion, urinary tract infections, vision problems, diarrhea, dizziness, and rash. A man may experience side effects with one of these medications but not another.
The main obstacle to men using an erectile dysfunction drug is often its cost, says Dr. Liou. Some insurers limit men to as few as four pills a month. After using up his ration, a man’s out-of-pocket cost for a single pill can be as high as $ 20.
It pays to shop around, because pharmacy prices vary. Various web-based tools can help men easily compare prices. Men may be able to save money by splitting higher-dose pills. And some manufacturer discount programs help men get a limited supply of medication not covered by insurance.
Read the full-length article: “Which drug for erectile dysfunction?”
Also in the June 2014 issue of the Harvard Men’s Health Watch: